아미노퀴놀린 화합물, 이의 제조 방법 및 이를 함유하는 의약 조성물
    2.
    发明公开
    아미노퀴놀린 화합물, 이의 제조 방법 및 이를 함유하는 의약 조성물 失效
    氨基喹啉衍生物,其制备方法和包含其的药物组合物

    公开(公告)号:KR1020100107326A

    公开(公告)日:2010-10-05

    申请号:KR1020090025560

    申请日:2009-03-25

    CPC classification number: C07D215/233 A61K31/47 C07D401/12 C07D413/12

    Abstract: PURPOSE: A novel aminoquinoline compound or pharmaceutically acceptable salt thereof are provided to ensure anti-proliferative efficiency with respect to melanoma and to prevent or treat skin cancer. CONSTITUTION: An amino quinoline compound is denoted by chemical formula 1. A method for preparing the amino quinoline compound or pharmaceutically acceptable salt thereof comprises: a step of performing nitration of a compound of chemical formula 2 to obtain a compound of chemical formula 3; a step of substituting the compound of chemical formula 3 to amino phenol compound to obtain a compound of chemical formula 4; a step of coupling the compound of chemical formula 4 with carboxylic acid compound of general formula R^5-CO_2H or isocyanate of general formula R^5-NCO to obtain a compound of chemical formula 5; a step of reducing the compound of chemical formula 5 to obtain a compound of chemical formula 6; a step of performing amidation of the compound of chemical formula 6 with carboxylic acid of general formula R^4-CO_2H. A pharmaceutical composition for preventing or treating skin cancer contains aminoquinoline compound of chemical formula 1 or pharmaceutically acceptable salt thereof as an active ingredient.

    Abstract translation: 目的:提供一种新的氨基喹啉化合物或其药学上可接受的盐以确保相对于黑素瘤的抗增殖效能并预防或治疗皮肤癌。 构成:氨基喹啉化合物由化学式1表示。氨基喹啉化合物或其药学上可接受的盐的制备方法包括:对化学式2的化合物进行硝化以获得化学式3的化合物的步骤; 将化学式3的化合物代替氨基酚化合物以获得化学式4的化合物的步骤; 将化学式4的化合物与通式为R 5,-CO 2 H的羧酸化合物或通式为R 5,NCO的异氰酸酯偶联,得到化学式5化合物的步骤; 还原化学式5的化合物以获得化学式6的化合物的步骤; 用通式为R 4 -OR-CO 2 H的羧酸进行化学式6的化合物的酰胺化反应的步骤。 用于预防或治疗皮肤癌的药物组合物含有化学式1的氨基喹啉化合物或其药学上可接受的盐作为活性成分。

Patent Agency Ranking